AMYLYX PHARMACEUTICALS INC

Ticker: AMLX CUSIP: 03237H101 Class: Common Stock

Qube Research & Technologies Ltd's Holding History (CIK: 0001729829)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 412,873 Value ($000) $4,988 Avg Close $13.58 Range $11.69 - $16.96
Q3 2025
Shares 167,106 Value ($000) $2,271 Avg Close $9.41 Range $5.97 - $15.14
Q2 2025
Shares 438,026 Value ($000) $2,808 Avg Close $4.86 Range $3.11 - $6.70
Q1 2025
Shares 942,891 Value ($000) $3,338 Avg Close $3.56 Range $2.60 - $4.18
Q4 2024
Shares 780,566 Value ($000) $2,951 Avg Close $4.71 Range $2.91 - $7.27
Q3 2024
Shares 183,894 Value ($000) $596 Avg Close $2.25 Range $1.62 - $3.33
Q2 2024
Shares 789,127 Value ($000) $1,499 Avg Close $1.94 Range $1.57 - $2.89
Q1 2024
Shares 944,063 Value ($000) $2,681 Avg Close $13.08 Range $2.67 - $19.95
Q4 2023
Shares 482,599 Value ($000) $7,104 Avg Close $15.33 Range $11.82 - $18.88
Q3 2023
Shares 162,710 Value ($000) $2,979 Avg Close $21.15 Range $17.80 - $25.48
Q2 2023
Shares 124,180 Value ($000) $2,679 Avg Close $27.01 Range $20.79 - $31.77
Q1 2023
Shares 31,725 Value ($000) $931 Avg Close $34.74 Range $26.64 - $41.93